Tobias Nordström

Tobias Nordström

Affiliated to Research | Docent
Visiting address: Entrévägen 2, 18257 Danderyd
Postal address: D1 Kliniska vetenskaper, Danderyds sjukhus, D1 Kirurgi och urologi, 182 88 Stockholm

About me

  • Clinical urologist and researcher dedicated to improve diagnostics and
    treatment of prostate cancer and other urological conditions.
    Tobias Nordström is a clinically active urologist, focusing on the detection
    and treatment of malignancies in the prostate and kidney, as well as treating
    general urological conditions. He started practicing urology in 2007
    and has achieved degrees in General Surgery and Urology at Danderyd's
    Hospital. He was awarded Fellow of the European Board of Urology (FEBU) in
    Tobias Nordström defended his thesis "Predicting Prostate Cancer- on the
    use of biomarkers in Prostate Cancer Diagnostics [1]" in January 2015 after
    which he undertook international postdoctoral studies at University of
    California, San Francisco.
    He now combines clinical surgical practice at Danderyds Hospital
    with independent research at the Department of Medical Epidemiology and
    Biostatistics at Karolinska Institutet. Centrepieces of his work includes
    leading guidelines development and implementing improvements in clinical care
    such as targeted prostate biopsies and imaging.
    2017 European Meeting on Urinary Cancers (EMUC) - Best poster award [2]
    2017 Astellas Cutting Edge Award
    2016 European Association of Urology (EAU) Annual Meeting - Best poster
    2014 StratCan International Postdoc award
    2011 StratCan Ph.D. award
    2011 Research Resident
    * 2015- Postdoc (Dept of Medical Epidemiology and Biostatistics, KI)
    * 2015- Clinical Urologist (Danderyd's Hospital)
    * 2015 Fellow of the European Board of Urology (FEBU)
    * 2015 Postdoc (University of California, San Francisco)
    * 2015 Ph.D. (Dept Clinical Sciences at Danderyd's Hospital, KI)
    * 2013 General Surgeon (Danderyd's Hospital)
    * 2007 M.D. (KI)


  • The over-arching aim of Tobias Nordström's research is to improve detection
    and treatment of prostate cancer. Current work emanates from different
    perspectives, resulting in several different projects.
    *An improved diagnostic chain for prostate cancer*
    The hypothesis is that combining improved blood-based testing and imaging
    techniques will improve detection of prostate cancer. Tobias Nordström
    is principal investigator for the STHLM3MR-projects, aiming to investigate
    the value of Magnetic Resonance Imaging (MRI) in prostate cancer detection.
    The STHLM3MR Main study [1] is a large randomized study, exploring a
    combination of using the STHLM3 test and targeted biopsies using MRI/Fusion
    *Traditional tools for prostate cancer detection*
    Several tools are already available to aid decisions in prostate cancer
    diagnostics, but evidence is often scarce. Using contemporary, high-quality
    data, Dr Nordström systematically explores the value of traditionally used
    markers of prostate cancer risk such as prostate volume, voiding symptoms,
    repeated blood-testing et cetera.
    *Current diagnostics of prostate cancer*
    Using the population-based cohort STHLM0, Dr Nordström works on describing
    how detection of prostate cancer is currently being performed. For example,
    he has described current patterns of PSA-testing, use of prostate biopsies
    and frequency of biopsy-related complications.


All other publications


  • Affiliated to Research, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2024-2026
  • Affiliated to Research, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2022-2025

Degrees and Education

  • Docent, Karolinska Institutet, 2021
  • Degree Of Doctor Of Philosophy, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2015
  • University Medical Degree, Karolinska Institutet, 2005

News from KI

Events from KI